A Phase 1b, Open Label, Multiple Dose, Dose Escalation and Expansion Study to Assess Safety, Tolerability and Antitumor Activities of the Combination of BGB-3111 with BGB-A317 in Subjects with B-Cell Lymphoid Malignancies

Project: Research

NMA Reference Number: HREC/16/PMCC/8.
SSA Reference Number: SSA/16/MonH/166.
Monash Health HREC Ref: 16228X

Status	Finished
Effective start/end date	30/04/19 → 29/04/24

Project Details